Dr Alexander Wilke

Dr. Alexander Wilke is a seasoned professional with extensive experience in market access and pricing within the healthcare sector. Currently serving as Senior Director of Global Market Access & Pricing at Norgine since December 2022, Dr. Wilke also leads as Scientific Director and CEO at the Institute for Evidence-Based Market Access and Health System Management, focusing on innovative healthcare solutions. Additional roles include Scientific Team Lead for the Neuromodulation of Cerebral Structures at the Human Brain Project and previous leadership positions at Ipsen Pharma GmbH, CSL Behring, and Roche. Dr. Wilke holds a Master of Science in Neuroscience from Harvard Graduate School of Education and a Doctorate in Human Biology from the Philipp University of Marburg, alongside advanced degrees in medical social law and healthcare economics.